返回 Agenda
Session Chair(s)
Luca De Nigro, MS
Drugs Monitoring Register
Italian Medicines Agency (AIFA), Italy
Speaker(s)
New Therapeutic Paradigms, Real-life Data Development and Adaptive Health Technology Assessment
Paolo Morgese, MSC
Alliance for Regenerative Medicine (ARM), Belgium
Head of Public Affairs
Early Benefit Assessment in Germany – impact on pricing and licensing in the EU
Burkhard Straeter
Sträter Rechtsanwälte, Germany
Lawyer
How to Manage Risks and Obtain Benefits with Wide Collaboration among Stakeholders - examples on the field
Eric Low
Myeloma UK, United Kingdom
Chief Executive